A Cochrane review [Abstract] 1 included 8 studies with a total of 343 subjects aged 18 years or younger with a diagnosis of obsessive-compulsive disorder (OCD). The review found evidence for lower post-treatment OCD severity and reduced risk of continuing with OCD for the behavioural or cognitive-behavioural therapy (BT/CBT) group compared to pill placebo or wait-list comparisons. There was no evidence found that the efficacy of BT/CBT alone and medication alone differ in terms of post treatment symptom severity or in the risk of having OCD. There was some evidence of a benefit for combined BT/CBT and medication compared to medication alone but not relative to BT/CBT alone. The low rates of drop out suggested BT/CBT is an acceptable treatment to child and adolescent patients and their families.
Comment: The quality of evidence is downgraded by study quality (unclear allocation concealment).
Primary/Secondary Keywords